ArticleContemporary clinical trials communications2025
Phase 1 clinical trial on Orgasmic Meditation (OM): Assessing safety and feasibility as a meditation practice for individuals with PTSD.
Daniel Kriegman et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.